Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Diagnostics (Basel, Switzerland)|December 9, 2023
Plasma Dephosphorylated-Uncarboxylated Matrix Gla-Protein in Systemic Sclerosis Patients: Biomarker Potential for Vascular Calcification and InflammationJudith Potjewijd, Rachid Tobal, Karin A Boomars, et al.
Autoimmunity|October 3, 2013
Functional implications of IgG anti-endothelial cell antibodies in pulmonary arterial hypertensionSteven J Arends, Jan G M C Damoiseaux, Adriaan M Duijvestijn, et al.
Pulmonary Circulation|May 18, 2026
Sotatercept in TBX4 Associated Heritable Pulmonary Arterial Hypertension: A Case Report of a Super ResponderJop W Schneijdenberg, Annemien E van den Bosch, Miriam E Kap, et al.
American Heart Journal|May 9, 2022
Prognostic value of brain natriuretic peptides in patients with pulmonary arterial hypertension: A systematic review and meta-analysisPaul M Hendriks, Liza D van de Groep, Kevin M Veen, et al.
Thorax|May 8, 2021
Loss of immune homeostasis in patients with idiopathic pulmonary arterial hypertensionPeter Heukels, Odilia B J Corneth, Denise van Uden, et al.
Journal of Clinical Medicine|April 30, 2020
Lower Plasma Melatonin Levels Predict Worse Long-Term Survival in Pulmonary Arterial HypertensionZongye Cai, Theo Klein, Laurie W Geenen, et al.
International Journal of Molecular Sciences|June 24, 2022
Peripheral Blood T Cells of Patients with IPAH Have a Reduced Cytokine-Producing CapacityDenise van Uden, Thomas Koudstaal, Jennifer A C van Hulst, et al.
Pulmonary Circulation|October 21, 2022
The evolution of survival of pulmonary arterial hypertension over 15 yearsPaul M Hendriks, Diederik P Staal, Liza D van de Groep, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 19, 2011
WITHDRAWN: Predictors of long-term survival in pulmonary hypertension treated with bosentanPaul Bresser, Jeroen C Vis, Rolf M Berger, et al.
Pageof 3